搜索
市场行情
自选
新闻
分析
交易工具
选股器
扫码下载
一键诊股 让投资更聪明
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
登录
免费注册
搜索
免费注册
市场行情
/
股票
/
医药与医学研究
/
药品
/
vrca
/
财务摘要
Verrica Pharmaceuticals Inc
VRCA
添加自选
4.450
USD
-0.200
-4.30%
收盘 09-18 16:00(美东)
77.48M
总市值
亏损
市盈率 TTM
Verrica Pharmaceuticals Inc
4.450
-0.200
-4.30%
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
财报
公司估值
风险评估
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
财报
公司估值
风险评估
VRCA 财务数据
通过专为投资者打造的一站式数据看板,全面查看 Verrica Pharmaceuticals Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。
关键财务比率
总市值
77.48M
股息TTM
0.00
市盈率 TTM
-4.08
每股收益TTM
-1.11
营业收入
35.58M
净利润
-76.58M
净资产收益率
-240.35%
总资产收益率
-44.03%
Verrica Pharmaceuticals Inc 财报日历
最新发布
8月 6, 2026
每股收益 / 预测值
-0.62
/-0.38
营业收入 / 预测值
5.86M
/5.73M
财务报表摘要
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
财务指标
每股收益
-2971.49%
-0.62
55.76%
-0.45
76.24%
-0.57
99.41%
-0.03
100.58%
0.02
76.51%
-1.03
54.79%
-2.40
9.27%
-4.88
-54.41%
-3.70
-185.59%
-4.37
-268.80%
-5.31
--
-5.38
--
-2.39
--
-1.53
--
-1.44
--
-0.58
--
--
--
--
--
--
--
--
营业收入
-53.85%
5.86M
46.06%
5.02M
1380.23%
5.09M
905.39%
14.34M
145.35%
12.70M
-10.12%
3.44M
-82.70%
344.00K
-161.06%
-1.78M
2744.51%
5.18M
10240.54%
3.83M
2823.53%
1.99M
-64.94%
2.92M
-14.95%
182.00K
-91.42%
37.00K
--
68.00K
--
8.32M
--
214.00K
-96.41%
431.00K
--
0.00
--
0.00
净利润
-6547.55%
-13.15M
0.62%
-9.68M
50.17%
-8.07M
98.80%
-274.00K
101.19%
204.00K
52.08%
-9.74M
34.18%
-16.20M
7.83%
-22.86M
-56.38%
-17.19M
-208.56%
-20.33M
-314.94%
-24.61M
-29981.93%
-24.80M
-8.08%
-10.99M
22.21%
-6.59M
37.82%
-5.93M
100.65%
83.00K
13.65%
-10.17M
-804.91%
-8.47M
26.49%
-9.54M
-22.34%
-12.83M
利润率
-14070.76%
-224.38%
31.96%
-192.75%
96.63%
-158.56%
--
-1.91%
100.48%
1.61%
46.69%
-283.28%
-280.40%
-4709.88%
--
--
94.50%
-331.97%
97.02%
-531.39%
85.81%
-1238.13%
--
-850.26%
--
-6038.46%
--
-17808.11%
--
-8723.53%
--
-206.99%
--
--
--
--
--
--
--
--
毛利率
-11.54%
85.02%
-5.72%
82.30%
188.74%
72.49%
--
92.27%
7.35%
96.11%
24.25%
87.29%
-194.63%
-81.69%
--
--
254.23%
89.53%
183.85%
70.26%
108.93%
86.32%
--
90.74%
--
25.27%
--
-83.78%
--
-966.18%
--
100.00%
--
--
--
--
--
--
--
--
资产负债率
-96.03%
3.87%
-97.54%
2.43%
-97.33%
2.22%
-38.79%
85.76%
12.16%
97.55%
44.45%
98.66%
53.34%
83.20%
220.16%
140.11%
--
86.97%
--
68.30%
--
54.26%
--
43.76%
--
--
--
--
--
0.00%
--
0.00%
--
--
--
--
--
--
--
--
利润表
营业收入
-53.85%
5.86M
46.06%
5.02M
1380.23%
5.09M
905.39%
14.34M
145.35%
12.70M
-10.12%
3.44M
-82.70%
344.00K
-161.06%
-1.78M
2744.51%
5.18M
10240.54%
3.83M
2823.53%
1.99M
-64.94%
2.92M
-14.95%
182.00K
-91.42%
37.00K
--
68.00K
--
8.32M
--
214.00K
-96.41%
431.00K
--
0.00
--
0.00
营业利润
-854.90%
-11.40M
-19.50%
-9.71M
38.68%
-6.95M
107.86%
1.63M
109.93%
1.51M
56.29%
-8.13M
45.01%
-11.33M
13.43%
-20.70M
-30.91%
-15.21M
-162.36%
-18.60M
-231.65%
-20.60M
-1751.73%
-23.92M
-27.35%
-11.62M
4.33%
-7.09M
26.67%
-6.21M
112.30%
1.45M
15.00%
-9.12M
-12450.00%
-7.41M
29.61%
-8.47M
-22.11%
-11.77M
净利润
-6547.55%
-13.15M
0.62%
-9.68M
50.17%
-8.07M
98.80%
-274.00K
101.19%
204.00K
52.08%
-9.74M
34.18%
-16.20M
7.83%
-22.86M
-56.38%
-17.19M
-208.56%
-20.33M
-314.94%
-24.61M
-29981.93%
-24.80M
-8.08%
-10.99M
22.21%
-6.59M
37.82%
-5.93M
100.65%
83.00K
13.65%
-10.17M
-804.91%
-8.47M
26.49%
-9.54M
-22.34%
-12.83M
资产负债表
流动资产
-11.26%
32.64M
-13.54%
34.13M
-16.88%
42.54M
28.69%
36.27M
-22.27%
36.78M
-35.68%
39.47M
-33.99%
51.18M
-69.27%
28.19M
-16.66%
47.32M
-2.73%
61.38M
98.21%
77.53M
111.37%
91.72M
-0.98%
56.78M
-4.07%
63.10M
-47.38%
39.12M
-47.82%
43.40M
-38.59%
57.34M
-35.55%
65.77M
9.87%
74.33M
12.42%
83.16M
流动负债总额
-23.20%
22.44M
-44.83%
16.22M
-43.34%
16.44M
37.49%
28.91M
45.74%
29.22M
51.80%
29.40M
70.42%
29.01M
84.86%
21.03M
249.87%
20.05M
632.69%
19.36M
392.17%
17.02M
269.53%
11.37M
-87.46%
5.73M
-94.10%
2.64M
-92.49%
3.46M
-93.36%
3.08M
0.95%
45.71M
0.32%
44.80M
16.67%
46.05M
18.90%
46.37M
总资产
-7.90%
36.02M
-8.04%
38.79M
-12.94%
47.13M
24.20%
40.90M
-24.81%
39.11M
-36.39%
42.18M
-33.66%
54.13M
-66.11%
32.93M
-16.38%
52.01M
-3.40%
66.31M
82.46%
81.60M
97.67%
97.15M
-1.95%
62.20M
-4.16%
68.64M
-44.19%
44.72M
-44.63%
49.15M
-35.94%
63.44M
-33.75%
71.62M
8.05%
80.13M
11.03%
88.76M
总负债
-43.97%
31.71M
-62.59%
22.73M
-65.02%
22.39M
-13.50%
57.94M
-13.35%
56.59M
-6.24%
60.75M
3.49%
63.99M
22.12%
66.98M
860.30%
65.31M
1608.38%
64.80M
1218.98%
61.83M
1151.60%
54.84M
-85.56%
6.80M
-91.79%
3.79M
-90.13%
4.69M
-90.85%
4.38M
0.49%
47.10M
-0.20%
46.20M
15.43%
47.52M
17.54%
47.90M
总权益
124.63%
4.31M
186.43%
16.05M
350.94%
24.74M
49.96%
-17.04M
-31.46%
-17.48M
-1331.83%
-18.58M
-149.89%
-9.86M
-180.49%
-34.05M
-124.01%
-13.30M
-97.67%
1.51M
-50.63%
19.76M
-5.50%
42.30M
239.19%
55.40M
155.12%
64.85M
22.78%
40.03M
9.58%
44.77M
-68.68%
16.33M
-58.88%
25.42M
-1.16%
32.60M
4.26%
40.85M
现金流量表
经营净额
7.63%
-9.28M
27.72%
-9.16M
71.42%
-4.59M
213.17%
9.69M
38.60%
-10.04M
36.45%
-12.68M
-10.73%
-16.06M
42.22%
-8.56M
-250.35%
-16.36M
-334.58%
-19.95M
-192.83%
-14.51M
-911.56%
-14.81M
34.98%
-4.67M
44.96%
-4.59M
43.04%
-4.95M
117.22%
1.82M
-387.35%
-7.18M
22.67%
-8.34M
-42.61%
-8.70M
-39.30%
-10.60M
投资净额
--
0.00
--
0.00
-100.00%
0.00
100.00%
0.00
100.00%
0.00
--
--
103.52%
8.00K
75.38%
-16.00K
81.36%
-11.00K
100.00%
0.00
-103.36%
-227.00K
-103.14%
-65.00K
-102.68%
-59.00K
-100.03%
-11.00K
68.39%
6.75M
-67.11%
2.07M
109.96%
2.21M
296.98%
43.01M
567.48%
4.01M
126.08%
6.29M
融资净额
96.97%
-126.00K
97.04%
-120.00K
-65.40%
13.64M
-903.53%
-3.98M
-549.22%
-4.16M
-513.77%
-4.06M
146122.22%
39.43M
-100.90%
-397.00K
-661.90%
-640.00K
-102.18%
-661.00K
--
-27.00K
361.37%
44.04M
-8300.00%
-84.00K
168322.22%
30.28M
100.00%
0.00
-39288.37%
-16.85M
-100.41%
-1.00K
-100.05%
-18.00K
-100.67%
-3.00K
--
43.00K
常见问题
Verrica Pharmaceuticals Inc的总收入是多少?
根据Verrica Pharmaceuticals Inc的FY2025财报,总收入达到了35.58M(同比变化7.57M)。
Verrica Pharmaceuticals Inc的流动资产是多少?
根据Verrica Pharmaceuticals Inc的FY2025财报,流动资产为42.54M(同比变化-16.88)。
Verrica Pharmaceuticals Inc的总资产是多少?
根据Verrica Pharmaceuticals Inc的FY2025财报,Verrica Pharmaceuticals Inc的总资产为47.13M(同比变化-12.94)。
Verrica Pharmaceuticals Inc的总负债是多少?
根据Verrica Pharmaceuticals Inc的FY2025财报,Verrica Pharmaceuticals Inc的总负债为22.39M(同比变化-65.02)。
Verrica Pharmaceuticals Inc的总权益是多少?
根据Verrica Pharmaceuticals Inc的FY2025财报,Verrica Pharmaceuticals Inc的总权益为24.74M(同比变化350.94)。
Verrica Pharmaceuticals Inc的净营业收入是多少?
根据Verrica Pharmaceuticals Inc的FY2025财报,Verrica Pharmaceuticals Inc的净营业收入为-11.94M(同比变化81.87)。
Verrica Pharmaceuticals Inc的净融资是多少?
根据Verrica Pharmaceuticals Inc的FY2025财报,Verrica Pharmaceuticals Inc的净融资为1.45M(同比变化-96.17)。
Verrica Pharmaceuticals Inc的每股收益(EPS)是多少?
根据Verrica Pharmaceuticals Inc的FY2025财报,每股收益(EPS)为-1.68(同比变化88.64)。
Verrica Pharmaceuticals Inc的净利润是多少?
根据Verrica Pharmaceuticals Inc的FY2025财报,净利润为-17.89M(同比变化76.64)。
Verrica Pharmaceuticals Inc的净利润率是多少?
根据Verrica Pharmaceuticals Inc的FY2025财报,净利润率为-50.27(同比变化95.03)。
Verrica Pharmaceuticals Inc的毛利率是多少?
根据Verrica Pharmaceuticals Inc的FY2025财报,毛利率为90.33(同比变化41.61)。
Verrica Pharmaceuticals Inc的债务与资产比率是多少?
根据Verrica Pharmaceuticals Inc的FY2025财报,债务与资产比率为2.22(同比变化-97.33)。
Verrica Pharmaceuticals Inc的股东权益回报率(ROE)是多少?
根据Verrica Pharmaceuticals Inc的FY2025财报,股东权益回报率(ROE)为-240.35(同比变化84.46)。
Verrica Pharmaceuticals Inc的资产回报率(ROA)是多少?
根据Verrica Pharmaceuticals Inc的FY2025财报,资产回报率(ROA)为-35.33(同比变化68.69)。
Verrica Pharmaceuticals Inc的营业利润是多少?
根据Verrica Pharmaceuticals Inc的FY2025财报,营业利润为-11.94M(同比变化81.87)。